Kaleido BioSciences Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 91
Employees
  • Stock Symbol
  • KLDO
Stock Symbol
  • Share Price
  • $7.45
  • (As of Tuesday Closing)

Kaleido BioSciences General Information

Description

Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 18 Crosby Drive
  • Bedford, MA 01730
  • United States
+1 (617) 000-0000

Kaleido BioSciences Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kaleido BioSciences Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.45 $7.75 $2.82 - $11.89 $265M 35.5M 277K -$2.63

Kaleido BioSciences Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 233,958 84,600
Revenue 250 0 0 0
EBITDA (77,539) (85,729) (61,065) (26,840)
Net Income (79,946) (86,331) (61,744) (27,559)
Total Assets 86,979 82,306 85,325 30,747
Total Debt 20,677 20,459 14,922 14,914
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kaleido BioSciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kaleido BioSciences‘s full profile, request access.

Request a free trial

Kaleido BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Kaleido BioSciences‘s full profile, request access.

Request a free trial

Kaleido BioSciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbi
Biotechnology
Bedford, MA
91 As of 2019
00000
0000 0000-00-00
00000000 00000

00000 00

illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000

00000 00

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat n
0000000000000
Cambridge, MA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kaleido BioSciences Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Seres Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000 000000 Venture Capital-Backed Brisbane, CA 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
You’re viewing 5 of 34 competitors. Get the full list »

Kaleido BioSciences Executive Team (18)

Name Title Board Seat Contact Info
Daniel Menichella Chief Executive Officer & Board Member
Rob Miller Ph.D President of Nutrition
William Duke Jr. Chief Financial Officer
Johan van Hylckama Vlieg Ph.D Chief Scientific Officer
Katharine Knobil MD Chief Medical Officer & Executive
You’re viewing 5 of 18 executive team members. Get the full list »

Kaleido BioSciences Board Members (17)

Name Representing Role Since
Alison Lawton Kaleido BioSciences Board Member 000 0000
Anne Prener MD Kaleido BioSciences Board Member 000 0000
Anthony Quinn Ph.D Self Board Member 000 0000
Daniel Menichella Kaleido BioSciences Chief Executive Officer & Board Member 000 0000
Geoffrey von Maltzahn Ph.D Self Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Kaleido BioSciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kaleido BioSciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kaleido BioSciences‘s full profile, request access.

Request a free trial